Clinical Therapeutics · 2020 · 37 citations · 18 references
MedicineEndocrinologyPharmacologyClinical PharmacologyEndocrine PharmacotherapyMolecular PharmacologyDiabetes ManagementG Protein-coupled Receptor SignalingGlucagon-like Peptide-1 Receptor AgonistsGlycemic ControlIncretin-based TherapiesReceptor BindingDual Incretin AgonistsG-protein-coupled ReceptorsGlp-1 Receptor PharmacologyLong-acting Glp-1 Receptor AgonistsSmall-molecule Glp-1 Receptor Agonists
18
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine · 2015 · 12K citations · Full text
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey et al. · New England Journal of Medicine · 2017 · 7.8K citations · Full text
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2016 · 7.3K citations · Full text
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca et al. · New England Journal of Medicine · 2018 · 6.3K citations · Full text
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Vlado Perkovic, Meg Jardine, Bruce Neal et al. · New England Journal of Medicine · 2019 · 6K citations · Full text
Medicine, Nephrology, Pharmacology +17